__timestamp | ACADIA Pharmaceuticals Inc. | HUTCHMED (China) Limited |
---|---|---|
Wednesday, January 1, 2014 | 120000 | 91813000 |
Thursday, January 1, 2015 | 61000 | 178203000 |
Friday, January 1, 2016 | 17331000 | 216080000 |
Sunday, January 1, 2017 | 124901000 | 241203000 |
Monday, January 1, 2018 | 223807000 | 214109000 |
Tuesday, January 1, 2019 | 339076000 | 204890000 |
Wednesday, January 1, 2020 | 441755000 | 227976000 |
Friday, January 1, 2021 | 484145000 | 356128000 |
Saturday, January 1, 2022 | 517235000 | 426409000 |
Sunday, January 1, 2023 | 726437000 | 837999000 |
Igniting the spark of knowledge
In the dynamic world of biopharmaceuticals, revenue growth is a key indicator of a company's success and market influence. Over the past decade, ACADIA Pharmaceuticals Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in their annual revenue growth. Starting in 2014, ACADIA's revenue was modest, but by 2023, it had skyrocketed by over 6,000%, reflecting a robust expansion strategy and successful product launches. In contrast, HUTCHMED's revenue growth, while steady, was more gradual, increasing by approximately 800% over the same period. This divergence highlights ACADIA's aggressive market penetration compared to HUTCHMED's steady, yet slower, growth. The data underscores the importance of strategic planning and market adaptation in the biopharmaceutical industry, where rapid innovation and competition are the norms.
Comparing Revenue Performance: Novartis AG or HUTCHMED (China) Limited?
Revenue Insights: GSK plc and ACADIA Pharmaceuticals Inc. Performance Compared
Revenue Showdown: Teva Pharmaceutical Industries Limited vs ACADIA Pharmaceuticals Inc.
Revenue Insights: Viatris Inc. and HUTCHMED (China) Limited Performance Compared
Revenue Insights: BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. Performance Compared
Breaking Down Revenue Trends: Catalent, Inc. vs HUTCHMED (China) Limited
Who Generates More Revenue? TG Therapeutics, Inc. or ACADIA Pharmaceuticals Inc.
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. and Galapagos NV: A Comprehensive Revenue Analysis
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Evotec SE
MorphoSys AG or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: HUTCHMED (China) Limited vs Galapagos NV